Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology Assessments.

Assessing programmed death ligand 1 (PD-L1) expression on tumor cells (TCs) using Food and Drug Administration-approved, validated immunoassays can guide the use of immune checkpoint inhibitor (ICI) therapy in cancer treatment. However, substantial interobserver variability has been reported using these immunoassays. Artificial intelligence (AI) has the potential to accurately measure biomarker expression in tissue samples, but its reliability and comparability to standard manual scoring remain to be evaluated. This multinational study sought to compare the %TC scoring of PD-L1 expression in advanced urothelial carcinoma, assessed by either an AI Measurement Model (AIM-PD-L1) or expert pathologists. The concordance among pathologists and between pathologists and AIM-PD-L1 was determined. The positivity rate of ≥ 1%TC PD-L1 was between 20-30% for 8/10 pathologists, and the degree of agreement and scoring distribution for among pathologists and between pathologists and AIM-PD-L1 was similar both scored as a continuous variable or using the pre-defined cutoff. Numerically higher score variation was observed with the 22C3 assay than with the 28-8 assay. A 2-h training module on the 28-8 assay did not significantly impact manual assessment. Cases exhibiting significantly higher variability in the assessment of PD-L1 expression (mean absolute deviation > 10) were found to have patterns of PD-L1 staining that were more challenging to interpret. An improved understanding of sources of manual scoring variability can be applied to PD-L1 expression analysis in the clinical setting. In the future, the application of AI algorithms could serve as a valuable reference guide for pathologists while scoring PD-L1.

High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma.

Reliable, reproducible methods to interpret programmed death ligand-1 (PD-L1) expression on tumor cells (TC) and immune cells (IC) are needed for pathologists to inform decisions associated with checkpoint inhibitor therapies. Our international study compared interpathologist agreement of PD-L1 expression using the combined positive score (CPS) under standardized conditions on samples from patients with gastric/gastroesophageal junction/esophageal adenocarcinoma. Tissue sections from 100 adenocarcinoma pretreatment biopsies were stained in a single laboratory using the PD-L1 immunohistochemistry 28-8 and 22C3 (Agilent) pharmDx immunohistochemical assays. PD-L1 CPS was evaluated by 12 pathologists on scanned whole slide images of these biopsies before and after a 2-hour CPS training session by Agilent. Additionally, pathologists determined PD-L1-positive TC, IC, and total viable TC on a single tissue fragment from 35 of 100 biopsy samples. Scoring agreement among pathologists was assessed using the intraclass correlation coefficient (ICC). Interobserver variability for CPS for 100 biopsies was high, with only fair agreement among pathologists both pre- (range, 0.45-0.55) and posttraining (range, 0.56-0.57) for both assays. For the 35 single biopsy samples, poor/fair agreement was also observed for the total number of viable TC (ICC, 0.09), number of PD-L1-positive IC (ICC, 0.19), number of PD-L1-positive TC (ICC, 0.54), and calculated CPS (ICC, 0.14), whereas calculated TC score (positive TC/total TC) showed excellent agreement (ICC, 0.82). Retrospective histologic review of samples with the poorest interpathologist agreement revealed the following as possible confounding factors: (1) ambiguous identification of positively staining stromal cells, (2) faint or variable intensity of staining, (3) difficulty in distinguishing membranous from cytoplasmic tumor staining, and (4) cautery and crush artifacts. These results emphasize the need for objective techniques to standardize the interpretation of PD-L1 expression when using the CPS methodology on gastric/gastroesophageal junction cancer biopsies to accurately identify patients most likely to benefit from immune checkpoint inhibitor therapy.

High interobserver and intraobserver reproducibility among pathologists assessing PD-L1 CPS across multiple indications.

AIMS: A common concern among pathologists scoring PD-L1 immunohistochemical staining is interobserver and intraobserver variability. We assessed the interobserver and intraobserver reproducibility of PD-L1 scoring among trained pathologists using a combined positive score (CPS; tumour cell and tumour-associated immune cell staining). METHODS AND RESULTS: Data were collected for 2 years (2017-2019) from 456 pathologists worldwide. Digital training encompassed unique, tumour-specific training, and test sets. Samples were stained using PD-L1 IHC 22C3 pharmDx and evaluated at specific CPS cutoffs for gastric cancer (GC), cervical cancer (CC), urothelial cancer (UC), oesophageal cancer (OC), and head and neck squamous cell carcinoma (HNSCC). Pathologists underwent expert-to-peer training and scored 20 blinded samples on day 1 and 25 blinded samples on day 2 (including 15 of the day 1 samples). Interobserver and intraobserver reproducibility were assessed. For GC (120 observers) and CC (32 observers) samples assessed at CPS ≥1, average interobserver agreement was 91.5% and 91.0%, respectively, and average intraobserver agreement was 90.2% and 96.6%, respectively. For UC (139 observers) and OC (52 observers) samples measured at CPS ≥10, average interobserver agreement was 93.4% and 93.7%, respectively, and average intraobserver agreement was 92.0% and 92.5%, respectively. For HNSCC samples (113 observers), average interobserver agreement was 94.1% at CPS ≥1 and 86.5% at CPS ≥20; intraobserver agreement was 94.7% at CPS ≥1 and 90.5% at CPS ≥20. CONCLUSION: The consistently high interobserver and intraobserver concordance rates support the effectiveness of face-to-face training of many global pathologists for scoring PD-L1 CPS across multiple indications at several specific cutoffs.

More Than Just a Reagent: The Rise of Renewable Organohydrides for Catalytic Reduction of Carbon Dioxide.

Stoichiometric carbon dioxide reduction to highly reduced C1 molecules, such as formic acid (2e- ), formaldehyde (4e- ), methanol (6e- ) or even most-reduced methane (8e- ), has been successfully achieved by using organosilanes, organoboranes, and frustrated Lewis Pairs (FLPs) in the presence of suitable catalyst. The development of renewable organohydride compounds could be the best alternative in this regard as they have shown promise for the transfer of hydride directly to CO2 . Reduction of CO2 by two electrons and two protons to afford formic acid by using renewable organohydride molecules has recently been investigated by various groups. However, catalytic CO2 reduction to ≥2e- -reduced products by using renewable organohydride-based molecules has rarely been explored. This Minireview summarizes important findings in this regard, encompassing both stoichiometric and catalytic CO2 reduction.

Room temperature phosphorescent triarylborane functionalized iridium complexes.

We report a series of room temperature phosphorescent compounds 1-6 composed of triarylborane (TAB) and cyclometallated iridium complexes. The optical characteristics such as energy of transition and luminescence quantum yield of these compounds can be conveniently fine-tuned by judiciously varying the cyclometallating ligand and the spacer between boron and iridium centers. Compounds 1-6 exhibit bright phosphorescence with the emission color ranging from green to red under a N2 atmosphere. A maximum quantum yield of 0.95 was observed for complex 2. Complexes 1-6 exhibit a rare type of dual emission from singlet and triplet excited states under ambient conditions. The experimental observations are well supported by the theoretical calculations.

Tuning the Phosphorescence and Solid State Luminescence of Triarylborane-Functionalized Acetylacetonato Platinum Complexes.

A new series of luminescent cyclometalated platinum complexes with triarylborane-functionalized acetylacetonate ligands is reported. The complexes exhibit solid state luminescence and phosphorescence under ambient conditions. The luminescence color can be tuned from green to red by varying the cyclometalating ligand [2-phenylpyridine (for 1 and 2), 2-thiophenylpyridine (for 3 and 4), 2-thianapthenylpyridine (for 5 and 6)]. The luminescence originates from mixed 3MLCT/3IL [MLCT, metal to ligand charge transfer; IL, intraligand] states of square planar platinum and borane moieties. The π spacer (phenyl or duryl) which connects the boryl and platinum entities has a significant role in determining the photoluminescence efficiency. The bulky duryl spacer in 2, 4, and 6 significantly reduces π-π stacking of the square planar platinum moiety in the solid state and provides a rigid backbone, thereby increasing their quantum yield significantly. The role of Lewis-acidic borane on the photoluminescence features is evaluated by fluoride binding experiments.

Aggregation-Induced Emission and Sensing Characteristics of Triarylborane-Oligothiophene-Dicyanovinyl Triads.

The design, synthesis and aggregation-induced emission properties of a new series of triarylborane-oligothiophene-dicyanovinyl (DCV) conjugates 4-6 (A-D-A' type molecular configuration) are reported. The optical properties of 4-6 can be modulated by judiciously varying the number of thiophene units between electron deficient boryl and dicyanovinyl units. Compound 6 with terthiophene spacer showed highly red-shifted absorption and emission compared to 5 and 4 with bithiophene and monothiophene spacers, respectively. Compounds 5 and 6 show aggregation-induced emission enhancement in water/THF mixtures. Compounds 5 and 6 also showed solvent viscosity dependent emission characteristics. All the three compounds show distinct optical responses for small anions such as fluoride and cyanide. Filter paper strips coated with compounds 5 and 6 can detect F- and CN- in aqueous media with different colorimetric responses.

White light emissive molecular siblings.

The design and synthesis of two structurally close and complementarily fluorescent boron based molecular siblings 2 and 3 are reported. The luminescence properties of individual triads are modulated to complement each other by controlling the intramolecular energy transfer in 2 and 3. The binary mixture of 2 and 3 emits white-light.

Triarylborane conjugated dicyanovinyl chromophores: intriguing optical properties and colorimetric anion discrimination.

Three new triarylborane conjugated dicyanovinyl chromophores (Mes2B-π-donor-DCV); donor: N-methyldiphenylamine () and triphenylamine ( and [with two BMes2 substitutions]) of type A-D-A (acceptor-donor-acceptor) are reported. Compounds exhibit intense charge transfer (CT) absorption bands in the visible region. These absorption peaks are combination CT bands of the amine donor to both the BMes2 and DCV units. This inference was supported by theoretical studies. Compound shows weak fluorescence compared to and . The discrimination of fluoride and cyanide ions is essential in the case of triarylborane (TAB) based anion sensors as a similar response is given towards both the anions. Anion binding studies of , and showed that fluoride ions bind selectively to the boron centre and block the corresponding CT transition (donor to BMes2) leaving the other CT transition to be red shifted. On the other hand, cyanide ions bind with both the receptor sites and stop both the CT transition processes and hence a different colorimetric response was noted. The binding of F(-)/CN(-) induces colour changes in the visible region of the electronic spectra of and , which allows for the naked-eye detection of F(-) and CN(-) ions. The anion binding mechanisms are established using NMR titration experiments.

Dicyanovinyl substituted triarylboranes: a rational approach to distinguish fluoride and cyanide ions.

Two new dicyanovinyl (DCV) functionalized triarylboranes (Mes2B-π-spacer-DCV, for 1: π-spacer = C6H4, for 2: π-spacer = 2,3,5,6-tetramethyl-phenyl) are reported. The molecular structures of 1 and 2 are similar except for the spacer which connects the boryl and DCV units. This small structural perturbation induces drastic changes in the optical properties of 1 and 2. Compound 2 shows weak dual fluorescence emission in nonpolar solvents and a stronger emission in polar solvents. Compound 1 is weakly fluorescent in polar environments but shows an intense single luminescence peak in less polar environments. Compound 1 exhibits a turn-off fluorescence response for both fluoride and cyanide: in contrast, 2 shows a turn on fluorescence response for both anions with different fluorescence signatures. The NMR titration studies reveal that for compound 2, fluoride binds to the boron centre and cyanide binds to the DCV unit. For compound 1, the fluoride ion binds to the boron center, whereas the CN(-) binds to both the Ar3B and DCV units.

Triarylborane conjugated acacH ligands and their BF2 complexes: facile synthesis and intriguing optical properties.

A facile synthetic route for a new class of organoborane compounds (Mes)2B-arene-acacH and (Mes)2B-arene-acacBF2 (Mes = mesityl and arene = C6H4 or C6Me4) is reported. The new dyads exhibit intriguing photophysical properties. A small structural change in spacer connecting the two chromophores leads to fine tuning of photophysical properties. The dyad containing 2,3,5,6-tetramethyl phenyl spacer acts as a selective "turn-on" chemodosimetric sensor for cyanide ion. Steric crowding around the boron centre significantly alters anion binding events. From NMR titration studies it is established that fluoride and cyanide follow different binding mechanisms which lead to intriguing optical properties in the reported probes.